{"nctId":"NCT00074815","briefTitle":"Treatment of Obsessive Compulsive Disorder in Children","startDateStruct":{"date":"2003-09"},"conditions":["Obsessive-Compulsive Disorder"],"count":124,"armGroups":[{"label":"MedMgmt+CBT","type":"EXPERIMENTAL","interventionNames":["Drug: Serotonin reuptake inhibitors management","Behavioral: Cognitive behavioral therapy by a psychologist"]},{"label":"MedMgmt+I-CBT","type":"EXPERIMENTAL","interventionNames":["Drug: Serotonin reuptake inhibitors management","Behavioral: Instructional cognitive behavioral therapy by a psychiatrist"]},{"label":"MedMgmt Only","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Serotonin reuptake inhibitors management"]}],"interventions":[{"name":"Serotonin reuptake inhibitors management","otherNames":["Drug Name with Minimum-Maximum Dosage","Citalopram (Celexa)10-60;","Escitalopram (Lexapro)5-30;","Fluoxetine (Prozac) 10-60;","Fluvoxamine (Luvox)25-300;","Paroxetine (Paxil)10-50;","Paroxetine-CR (Paxil)10-50;","Clomipramine (Anafranil)25-200;","Sertraline (Zoloft) 25-200;","Venlafaxine (Effexor)25-225;","Venlafaxine XR (Effexor)37.5-225;"]},{"name":"Cognitive behavioral therapy by a psychologist","otherNames":[]},{"name":"Instructional cognitive behavioral therapy by a psychiatrist","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* DSM-IV Diagnosis of obsessive compulsive disorder\n* CYBOCS total score greater than 16\n\nExclusion Criteria:\n\n* Other primary or co-primary psychiatric disorder\n* Pervasive developmental disorder or disorders, including Asperger's Syndrome\n* Thought disorder\n* Prior failed trial of cognitive-behavioral therapy\n* Has pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) or maintenance antibiotic for obsessive-compulsive disorder\n* Mental retardation\n* Pregnancy","healthyVolunteers":false,"sex":"ALL","minimumAge":"7 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)","description":"OCD symptom severity was measured using the CY-BOCS, an interviewer-rated instrument that assess obsessions and compulsions separately on time consumed, distress, interference, degree of resistance, and control; it yields separate severity scores for obsessions and for compulsions (0 - 20), and a composite symptom severity score (0 to 40).\n\nConsistent with signal detection analyses examining the optimal criterion for treatment response, a CY-BOCS reduction of 30% or more from baseline to week 12 was used as the criterion for RESPONSE and was the primary dichotomous outcome measure.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.69","spread":null},{"groupId":"OG001","value":"0.34","spread":null},{"groupId":"OG002","value":"0.30","spread":null}]}]}]},{"type":"SECONDARY","title":"Child Obsessive -Compulsive Impact Scale (COIS)","description":null,"classes":[]},{"type":"SECONDARY","title":"Child Depression Inventory","description":null,"classes":[]},{"type":"SECONDARY","title":"Pediatric Adverse Event Rating Scale (PAERS)","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":42},"commonTop":[]}}}